AC Immune SA (NASDAQ: ACIU) reported Q4 EPS of ($0.81), $0.56 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.94 million versus the consensus estimate of $1.6 million.

For earnings history and earnings-related data on AC Immune SA (ACIU) click here.